Search results for: Determining Value
Filter search results
An Update on the EQ-5D-5L Value Set for England
22 August 2017
…on the implications of new value sets for HTA and other uses. 1. What is the current status of the EQ-5D-5L value set for England? An English value set for…
Cornerstones of “Fair” Drug Coverage: Appropriate Cost – Sharing and Utilization Management Policies for Pharmaceuticals
1 September 2020
…that there is not a single drug that represents a fair value as determined through value assessment, it is reasonable for payers to have all drugs on a higher cost-sharing…
Moving the Needle on Value – OHE Launches Research on US Value-Based Healthcare
10 June 2019
At the recent ISPOR Annual Conference, OHE’s Chief Executive, Professor Graham Cookson announced a new programme of work on Value 2.0: Assessing the Value of US Healthcare to be funded…
The Case of Risperidone: Assessing the Life-cycle Value of Second-Generation Antipsychotics in Sweden and the UK
1 July 2019
…also estimates the absolute social value added, measured by the sum of the consumer and producer surpluses. Study results aim to quantify the nature of value added by pharmaceutical innovation…
How do we Measure the “Value” in Value-Based care?
1 October 2020
Determining and defining value in health care is a persistent challenge in every country. To some extent, what constitutes value depends on perspective, e.g. a pharmaceutical company may view value…
Combination Therapies: A Step Forward to the Value Attribution Problem
4 January 2023
…launched), and complete (all value is apportioned to the constituent therapies). The co-authors presented challenges surrounding attributing value to CTs and the proposed outcome-based value attribution framework. The new solution…
Do child QALYs = adult QALYs? Five reasons why they might not
4 February 2020
…values used to weight length of life in calculating QALYs – and the question of whether these values mean the same thing for child as for adult health states. There…
The Broader Value of Existing Vaccines in the Fight Against COVID-19: Beware of Tunnel Vision
8 October 2020
…– value that extends well beyond preserving the health of the vaccinated individual and avoiding the costs associated with COVID-19 disease. These broader value aspects are by no means unique…
OHE’s AMR consultation response
21 November 2023
…learnings for establishing effective pull incentives in other jurisdictions. Notes 1 Value band 2: ‘critical value’ is defined as 70-79, so technically this dummy surpasses value band 2, but does…